Characterization of NS5A polymorphisms and their impact on response rates in patients with HCV genotype 2 treated with daclatasvir-based regimens.
about
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents.Efficacy and Safety of Daclatasvir in Hepatitis C: An Overview.In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir.Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.
P2860
Characterization of NS5A polymorphisms and their impact on response rates in patients with HCV genotype 2 treated with daclatasvir-based regimens.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Characterization of NS5A polym ...... th daclatasvir-based regimens.
@en
type
label
Characterization of NS5A polym ...... th daclatasvir-based regimens.
@en
prefLabel
Characterization of NS5A polym ...... th daclatasvir-based regimens.
@en
P2093
P2860
P356
P1476
Characterization of NS5A polym ...... th daclatasvir-based regimens.
@en
P2093
Brenda DeGray
Dennis Hernandez
Fiona McPhee
Joseph Ueland
Nannan Zhou
Sandra Hartman-Neumann
Vincent Vellucci
P2860
P304
P356
10.1093/JAC/DKW336
P407
P577
2016-09-07T00:00:00Z